Another GLP-1 class drug, liraglutide, showed similar but slightly less pronounced effects, reducing alcohol-related hospitalizations by 28 percent
To achieve this, GLP-1s, along with the entire breadth of obesity treatments, must be prescribed with clinically rigorous behavior change programs, to give everyone a fair chance at sustained weight health.
Any antiemetic use should be discussed with the prescribing clinician
The altered autoregulation of blood flow cannot meet the metabolic demand of tissues in ME/CFS, leading to tissue hypoxia and subsequent ischaemia/reperfusion injury with its associated symptoms and signs (29)
Both medications work remarkably well, but tirzepatide shows a clear advantage in head-to-head comparisons